The global health and economic value of COVID-19 vaccination.

ABSTRACT:

Introduction

The COVID-19 pandemic triggered one of the largest global health and economic crises in recent history. COVID-19 vaccination (CV) has been the central tool for global health and macroeconomic recovery, yet estimates of CV's global health and macroeconomic value remain scarce.

Methods

We used regression analyses to measure the impact of CV on gross domestic product (GDP), infections and deaths. We combined regression estimates of vaccine-averted infections and deaths with estimates of quality-adjusted life years (QALY) losses, and direct and indirect costs, to estimate three broad value components: (i) QALY gains, (ii) direct and indirect costs averted and (iii) GDP impacts. The global value is the sum of components over 148 countries between January 2020 and Dec

SUBMITTER: Sevilla JP 

PROVIDER: S-EPMC11381632 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature